Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic.

Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic. Vasa. 2019 Mar;48(2):109-111 Authors: Zeller T, Noory E, Beschorner U, Böhme T, Mpj Reijnen M PMID: 30821214 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30821214?dopt=Abstract

Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - February 28, 2019 Category: Surgery Authors: Zeller T, Noory E, Beschorner U, Böhme T, Mpj Reijnen M Tags: Vasa Source Type: research

More News: Surgery